It is not approved by Health Canada for human or veterinary use
In preclinical studies, ALCAR reduced oxidative damage markers (lipid peroxidation, oxidized nucleotides, nitrotyrosine) in aged rat brains, while LCAR did not, despite both compounds similarly increasing ambulatory activity and tissue carnitine levels.[5] ALCAR also decreased infarction size in stroke models, whereas LCAR showed no protective effect in vivo, though both were neuroprotective in vitro.[6] These differences likely reflect ALCARs ability to donate acetyl groups for acetylcholine synthesis, energy production, and neurotransmitter metabolism.[2][7] For cardiovascular and metabolic applications, the compounds appear more comparable
The SL hydrolytic activity of ShHTLs and ShD14 is important for their function as SL receptors
RDS , vol
Additionally, individuals experiencing certain neurological symptoms or those with high levels of homocysteine, a risk factor for cardiovascular diseases, might find our B12 injections beneficial